🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

545 results for “B.” Clear

  1. A Phase I, Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HMPL-523 in Patients with Relapsed or Refractory Lymphoma

    Hutchmed Europe B.V.

    Lymphoma

    phase 1 other active

    1 trial

  2. A Phase I, Open-label, Multi-center, First-in-human Trial to Investigate E303, in Participants with Advanced Refractory Solid Tumors

    Samsung Bioepis NL B.V.

    advanced refractory solid tumors

    phase 1 other active

    1 trial

  3. A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma

    Alnylam Netherlands B.V.

    Advanced or Metastatic Hepatocellular Carcinoma

    phase 1 other active

    1 trial

  4. A Study to Evaluate ALN-HTT02 in Adult Patients with Huntington’s Disease

    Alnylam Netherlands B.V.

    Huntington’s disease

    phase 1 other active

    1 trial

  5. A clinical study to test MEN2501 in patients with treatment-resistant ovarian cancer

    Stemline Therapeutics B.V.

    ​​Platinum-Resistant ovarian cancer​

    phase 1 other active

    1 trial

  6. AG-120 (Ivosidenib)

    Agios Netherlands B.V.

    Hepatic Impairment

    phase 1 small molecule completed

    1 trial

  7. AG-181

    Agios Netherlands B.V.

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  8. AG-181

    Agios Netherlands B.V.

    Phenylketonuria

    phase 1 small molecule active

    1 trial

  9. AG-236

    Agios Netherlands B.V.

    Healthy Participants

    phase 1 small molecule active

    1 trial

  10. AG-348

    Agios Netherlands B.V.

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  11. AG-348

    Agios Netherlands B.V.

    Healthy

    phase 1 small molecule completed

    1 trial

  12. AG-348

    Agios Netherlands B.V.

    Sickle Cell Disease

    phase 1 small molecule completed

    1 trial

  13. AG-348

    Agios Netherlands B.V.

    Healthy Volunteer

    phase 1 small molecule completed

    2 trials

  14. AG-348 Sequence A

    Agios Netherlands B.V.

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  15. AG-519

    Agios Netherlands B.V.

    Anemia

    phase 1 small molecule terminated

    1 trial

  16. AG-636

    Agios Netherlands B.V.

    Lymphoma

    phase 1 small molecule terminated

    1 trial

  17. AG-881

    Agios Netherlands B.V.

    Healthy Participants

    phase 1 small molecule completed

    1 trial

  18. AG-881

    Agios Netherlands B.V.

    Healthy Male Participants

    phase 1 small molecule completed

    1 trial

  19. AG-946

    Agios Netherlands B.V.

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  20. AG120

    Agios Netherlands B.V.

    Healthy

    phase 1 small molecule completed

    2 trials

  21. AG221

    Agios Netherlands B.V.

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  22. AG881

    Agios Netherlands B.V.

    Acute Myeloid Leukemia (AML)

    phase 1 small molecule completed

    1 trial

  23. AG881

    Agios Netherlands B.V.

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  24. AG881 Formulation 1

    Agios Netherlands B.V.

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources